Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

Example Input: Paragraph: About 400 patients, many of them with cancer, were given the oil for free at a flagship clinic at the Public Health Ministry in a suburb of Bangkok. The initial four formulations handed out are used for treating conditions such as migraines, insomnia, nausea, numbness and pain. The medicines are touted as being based on traditional remedies. Thailand was previously known for harsh anti-drug laws, but is now eyeing the economic potential of cannabis. A report last year by Prohibition Partners, which claims to be the leading authority on the subject, said Asia’s medical cannabis market would be worth around $5.8 billion by 2024. Around 25 similar clinics have been operating part-time since the legislature agreed in 2018 to amend the country’s drug laws to allow the use and production of medical cannabis. The Health Ministry clinic and another in Bangkok are forerunners of a planned nationwide network, if they show positive results. “Marijuana could be an answer. At least the patients’ quality of life is improved,” said Dr. Prasert Mongkolsiri, the director of a public hospital, who helped advise patients on Monday. “At least it can lessen the side effects of the modern chemical-based medicines that they’ve been taking for 10 or 20 years,” he said, referring to chemotherapy for cancer patients. Chamroen Nakurai, 57, was diagnosed with lymph node cancer two years ago. She said cannabis oil helps lessen the side effects of her chemotherapy, but until now she had been able to get it only through illegal underground suppliers. “The treatment isn’t widely available and the cost is quite high if you visit underground clinics, but this service is free and anyone can access it,” she said. Nuthjutha Ulpathorn, 29, was born with cerebral palsy that makes her unable to walk and garbles her speech. She began to use cannabis oil two months ago after her mother brought her to a government hospital that started to give out cannabis oil. “I sleep better, and (am) less cranky,” Nuthjutha said with a smile. Health Minister Anutin Charnvirakul, the chief architect of the new policy drive, toured the suburban clinic on Monday. He expressed hope that the remedies might be soon added into the National List of Essential Medicine, which allows them to be covered by Thailand’s 30-baht ($1) universal health care scheme. Officials say the policy of free cannabis is likely to be changed. Anutin is the leader of the Bhumjai Thai Party, a partner in the country’s coalition government. The party won 50 seats in March’s general election after Anutin campaigned for legalization of the production of marijuana to aid farmers. Moves to allow small-scale private production are moving ahead. The Public Health Ministry, meanwhile, supervises cannabis production at six locations around the country. Claim: Thailand launches full-time clinics dispensing cannabis oil.
Example Output: Thailand on Monday opened its first two full-time clinics dispensing cannabis oil for medical treatment, a step forward in the government’s policy of promoting the licensed use of marijuana products to relieve the symptoms of a range of ailments.

Example Input: Paragraph: The company earned $728 million, or 67 cents per share, in the fourth quarter. That compared with $827 million, or 74 cents per share, in the year-earlier quarter, when Lilly took charges for asset impairments and restructuring. “Company sales were stronger than thought, but a lot of that upside came from drugs that are already off patent or about to lose patent protection,” said Edward Jones analyst Judson Clark. Excluding special items, Lilly earned 74 cents per share, matching analysts’ average forecasts, according to Thomson Reuters I/B/E/S. Shares in the company dropped 1.4 percent to 53.21, after earlier reaching their lowest in two weeks at $53.05. Lilly’s global sales fell 2 percent to $5.81 billion, but topped Wall Street forecasts of $5.46 billion. Sales would have been flat if not for the stronger dollar, which lowers the value of sales in overseas markets. Sales of Cymbalta, which lost U.S. patent protection last month, fell 38 percent to $883 million. But they came in about $100 million higher than Wall Street expected, analysts said. Lilly’s sales, earnings, and its share price, have been badly hurt since late 2011, when its Zyprexa schizophrenia drug lost U.S. patent protection. Once Lilly’s biggest product, with annual sales of $5 billion, it now has sales of only $1.5 billion. The situation worsened last month, when Cymbalta - which also had $5 billion in annual sales at its peak - began facing cheaper generics in the United States. The company’s “patent cliff” will become more daunting in March, when $1 billion-a-year osteoporosis drug Evista faces U.S. generics. “We haven’t wasted the crisis,” Chief Executive John Lechleiter said Thursday in a conference call with industry analysts. “We’re more agile, we’re leaner and I believe we’re better operators today.”  Lilly has cut more than 5,000 employees from its workforce in order to reduce annual costs by $1 billion over the last three years to deal with patent expirations on its drugs. It has also restructured itself to focus on cancer and diabetes - lucrative specialties that are two of the company’s longstanding strengths. Clark said sales of Cymbalta could eventually decline 80 percent, which has been the case for many other blockbuster medicines in recent years. He questioned whether gains for other products seen in the fourth quarter will be sustainable. Sales of many products over the quarter showed double-digit sales increases, including Lilly’s Humalog insulin, Cialis anti-impotence treatment, Forteo and Evista osteoporosis drugs, and Straterra for attention deficit disorder. But price increases in the United States accounted for much of those sales gains. The Indianapolis drugmaker is expecting a return to company sales growth next year, from increased sales of drugs that still have patent protection and from launches of new treatments for cancer and diabetes. It hopes to launch three new drugs this year: ramucirumab for stomach cancer, and dulaglutide and empagliflozin for type 2 diabetes - the most common form of the disease, which is closely linked to obesity. Although analysts have forecast annual sales of more than $650 million for ramucirumab, they are concerned the new diabetes drugs may have a hard time competing with similar drugs already on the market. The company has introduced no new products in recent years. In a recent interview, Lechleiter said it was time for Lilly “to go back on offense”, helped by a pipeline of nearly 40 medicines in mid- and late-stage studies, compared with only seven in those stages of development a decade ago. Claim: Lilly's quarterly sales largely offset Cymbalta slide.
Example Output: Drugmaker Eli Lilly and Co’s quarterly revenue fell far less than expected, it reported on Thursday, as plunging sales of its Cymbalta depression treatment were largely offset by higher revenues for most of its other prescription drugs.

Example Input: Paragraph: The order issued late Wednesday in connection with the University of California, Los Angeles, and California State University, Los Angeles, requires that affected people stay home, avoid contact with others and notify authorities if they develop measles symptoms. Los Angeles County public health officials issued quarantines of 24 to 48 hours until proof of immunity is established, according to a statement from UCLA. Some people may need to be quarantined for up to a week. “Please be assured that we have the resources we need for prevention and treatment, and that we are working very closely with local public health officials on the matter,” UCLA Chancellor Gene Block in the statement. Measles in the United States has climbed to its highest level in 25 years, closing in on 700 cases this year in a resurgence largely attributed to misinformation that is turning parents against vaccines. Roughly three-quarters of this year’s illnesses have been in New York state. A UCLA student who was diagnosed with measles possibly exposed 500 people on campus to measles in early April, according to a statement from the school. As of Thursday afternoon, 79 of those students and faculty members had not provided medical records showing that they are immune to measles, the university said. Meanwhile at Cal State, a person infected with measles visited a library and possibly encountered hundreds of employees, some of whom were students. A total of 156 of them could not provide their immunization records as of Thursday afternoon, according to a statement from the Cal State. Health officials determined that there is “no known current risk related to measles at the library at this time,” Cal State said in its statement. The orders come as a small outbreak of measles occurs in Los Angeles County involving five confirmed cases linked to overseas travel. The state recorded 38 measles cases as of Thursday; there were 11 around the same time last year, said Dr. Karen Smith, director of the California Department of Public Health. The state typically sees fewer than two dozen cases a year, she said. This year, California’s cases stretch across 11 counties and affect patients from 5 months old to 55. More than 76% of patients were not vaccinated or did not receive the recommended two doses of vaccine, Smith said. Fourteen of those infected had traveled overseas to countries including Philippines, Thailand, India and Ukraine. Measles in most people causes fever, runny nose, cough and a rash all over the body. However, a small fraction of those infected can suffer complications such as pneumonia and a dangerous swelling of the brain. The Centers for Disease Control and Prevention recommends the vaccine for everyone over a year old, except for people who had the disease as children. Those who have had measles are immune. The vaccine, which became available in the 1960s, is considered safe and effective, and because of it, measles was declared all but eliminated in the U.S. in 2000. ___ Associated Press Writer John Antczak contributed to this report. ___ Follow Weber at https://twitter.com/WeberCM Claim: Quarantines at 2 LA universities amid US measles outbreak.
Example Output:
More than 200 students and staff at two Los Angeles universities have been placed under quarantine because they may have been exposed to measles and either have not been vaccinated or cannot verify that they are immune, officials said Thursday.